7-Hydroxycoumarin

CAS No. 93-35-6

7-Hydroxycoumarin( 7-hydroxy Coumarin | NSC 19790 )

Catalog No. M16673 CAS No. 93-35-6

It is a widespread natural product of the coumarin family. It has been reported to have antioxidant properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 27 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Hydroxycoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    It is a widespread natural product of the coumarin family. It has been reported to have antioxidant properties.
  • Description
    It is a widespread natural product of the coumarin family. It has been reported to have antioxidant properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    7-hydroxy Coumarin | NSC 19790
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    93-35-6
  • Formula Weight
    162.14
  • Molecular Formula
    C9H6O3
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C1OC2=C(C=CC(O)=C2)C=C1
  • Chemical Name
    7-Hydroxycoumarin

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kabeya LM, et al. Chem Biol Interact. 2013 Oct 25;206(1):63-75.
molnova catalog
related products
  • Isosakuranetin

    Isosakuranetin has cytotoxic and fungicide properties. Isosakuranetin produces significant decrease in blood pressure.

  • γ-Glutamyl-S-allylcy...

    γ-Glutamyl-S-allylcysteine (L-γ-Glutamyl-(S)-Allyl-Cysteine) is a γ-glutamyl peptide derived from Allium sativum L., known for its anti-glycation and antioxidant properties, as well as its ability to inhibit cholesterol biosynthesis.

  • Dimethylacrylshikoni...

    Dimethylacrylshikonin is a promising agent for developing an improved strategy for radiotherapy against tumors.